Angelo Federico, DO | |
18101 Oakwood Blvd, Dearborn, MI 48124-4089 | |
(313) 593-7795 | |
Not Available |
Full Name | Angelo Federico |
---|---|
Gender | Male |
Speciality | Surgery |
Location | 18101 Oakwood Blvd, Dearborn, Michigan |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306539242 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208600000X | Surgery | 5151016258 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Angelo Federico, DO 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: () - | Angelo Federico, DO 18101 Oakwood Blvd, Dearborn, MI 48124-4089 Ph: (313) 593-7795 |
News Archive
Antipsychotic medication is frequently being prescribed to individuals with intellectual and developmental disabilities (IDD), often without a psychiatric diagnosis, a new study conducted by the Centre for Addiction and Mental Health and Institute for Clinical Evaluative Sciences has found.
In a significant advance for HIV prevention research, a clinical trial confirms that the same drugs used for treating HIV can also help prevent HIV infection in the first place.
Women enrolled in California's Medicaid program who have been diagnosed with severe mental illness have been screened for cervical cancer at much lower rates than other women, according to a new study by researchers at UC San Francisco.
While many young adults will share the details of their daily lives with friends on Facebook, communicating with their doctors about mental illness is another story. E-SMART-MH, developed at Case Western Reserve University, might improve those communications.
Abraxis BioScience, Inc. announced today that findings from a phase 1 randomized trial demonstrated that the nanoparticle albumin bound (nab®) driven chemotherapy, nab-paclitaxel (ABRAXANE® for Injectable Suspension; paclitaxel albumin protein-bound particles for injectable suspension) is well-tolerated and active in the second-line treatment of high-grade, non-muscle-invasive bladder cancer that has been refractory to standard intra-bladder infusion (intravesical) therapy.
› Verified 7 days ago
John J Fath, MD Surgery Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-982-5440 | |
Dr. Abubaker Ahmed Ali, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 13051 Osborne St, Apt 608, Dearborn, MI 48126 Phone: 313-878-7575 | |
Erik Rafael Gamarra, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-8660 | |
Guat Sia Sy Jr., MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 17000 Hubbard Dr, Suite 700, Dearborn, MI 48126 Phone: 313-271-2990 Fax: 313-271-1698 | |
Zachary Fent, DO, MS Surgery Medicare: Medicare Enrolled Practice Location: 18101 Oakwood Blvd, Dearborn, MI 48124 Phone: 313-593-7000 | |
Dr. Shadi M Fahs, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 23855 Michigan Ave, Dearborn, MI 48124 Phone: 313-769-5656 Fax: 313-769-5658 | |
Dr. Pradeep Srinivas Bhandarkar, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: Henry Ford Health System, 19401 Hubbard Drive, Suite#202, Dearborn, MI 48126 Phone: 313-982-8419 Fax: 313-982-4430 |